49
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Role of C1q/TNF-Related Protein 6 for the Evaluation of Coronary Heart Disease Associated with Type 2 Diabetes

, , & ORCID Icon
Pages 289-296 | Received 13 Feb 2024, Accepted 12 May 2024, Published online: 20 May 2024

References

  • Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401. doi:10.1186/s12889-021-10429-0
  • National Center for Cardiovascular Diseases. Annual Report on Cardiovascular Health and Diseases in China 2020; 2021.
  • Luxembourg F. Cardiovascular disease in Europe 2016: an epidemiological update. Eur Heart J. 2016;37(42):3182–3183. doi:10.1093/eurheartj/ehw468
  • Htay T, Soe K, Lopez-Perez A, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. Curr Cardiol Rep. 2019;21(6):45. doi:10.1007/s11886-019-1133-9
  • Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21(4):21. doi:10.1007/s11886-019-1107-y
  • Ali MK, Pearson-Stuttard J, Selvin E, et al. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3–13. doi:10.1007/s00125-021-05585-2
  • de Miguel-Yanes JM, Jimenez-Garcia R, Hernandez-Barrera V, et al. Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014). Cardiovasc Diabetol. 2017;16(1):126. doi:10.1186/s12933-017-0609-4
  • Liao X, Liu S, Tang X, et al. Circulating CTRP6 levels are increased in overweight or obese Chinese individuals and associated with insulin resistance parameters: a pilot study. Exp Clin Endocrinol Diabetes. 2021;129(7):535–541. doi:10.1055/a-0929-6072
  • Xie Y, Meng Z, Gao J, et al. C1q complement/tumor necrosis factor-associated proteins in cardiovascular disease and COVID-19. Proteomes. 2021;9(1):12. doi:10.3390/proteomes9010012
  • Sarver DC, Stewart AN, Rodriguez S, et al. Loss of CTRP4 alters adiposity and food intake behaviors in obese mice. Am J Physiol Endocrinol Metab. 2020;319(6):E1084–E1100. doi:10.1152/ajpendo.00448.2020
  • Schaffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab. 2012;23(4):194–204. doi:10.1016/j.tem.2011.12.003
  • Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord. 2014;15(2):111–123. doi:10.1007/s11154-013-9255-7
  • Chi L, Hu X, Zhang W, et al. Adipokine CTRP6 improves PPARgamma activation to alleviate angiotensin II-induced hypertension and vascular endothelial dysfunction in spontaneously hypertensive rats. Biochem Biophys Res Commun. 2017;482(4):727–734. doi:10.1016/j.bbrc.2016.11.102
  • Wang M, Tang X, Li L, et al. C1q/TNF-related protein-6 is associated with insulin resistance and the development of diabetes in Chinese population. Acta Diabetol. 2018;55(12):1221–1229. doi:10.1007/s00592-018-1203-2
  • Rampidis GP, Benetos G, Benz DC, et al. A guide for gensini score calculation. Atherosclerosis. 2019;287:181–183. doi:10.1016/j.atherosclerosis.2019.05.012
  • Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A. 2004;101(28):10302–10307. doi:10.1073/pnas.0403760101
  • Pan X, Lu T, Wu F, et al. Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects. PLoS One. 2014;9(5):e94478. doi:10.1371/journal.pone.0094478
  • Zhang C, Zhou N, Qiu P, et al. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease. Cytokine. 2018;110:52–57. doi:10.1016/j.cyto.2018.04.019
  • Moradi N, Fadaei R, Khamseh ME, et al. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. PLoS One. 2019;14(4):e0215617. doi:10.1371/journal.pone.0215617
  • Ilbeigi D, Khoshfetrat M, Afrisham R, et al. Serum C1q/TNF-related protein-2 (CTRP2) levels are associated with coronary artery disease. Arch Med Res. 2020;51(2):167–172. doi:10.1016/j.arcmed.2020.01.009
  • Ahmed SF, Shabayek MI, Abdel Ghany ME, et al. Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females. PLoS One. 2018;13(12):e0208038. doi:10.1371/journal.pone.0208038
  • Dong X, Hu H, Fang Z, et al. CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration. Biomed Pharmacother. 2018;103:844–850. doi:10.1016/j.biopha.2018.04.112
  • Song Y, Zhang Y, Wan Z, et al. CTRP3 alleviates myocardial ischemia/reperfusion injury in mice through activating LAMP1/JIP2/JNK pathway. Int Immunopharmacol. 2022;107:108681. doi:10.1016/j.intimp.2022.108681
  • Zhao D, Feng P, Sun Y, et al. Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Cell Death Dis. 2018;9(7):723. doi:10.1038/s41419-018-0726-3
  • Yanai H, Yoshida H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci. 2019;20(5):1190. doi:10.3390/ijms20051190
  • Xie Y-H, Xiao Y, Huang Q, et al. Role of the CTRP6/AMPK pathway in kidney fibrosis through the promotion of fatty acid oxidation. Eur J Pharmacol. 2021;892:173755. doi:10.1016/j.ejphar.2020.173755
  • Lahav R, Haim Y, Bhandarkar NS, et al. CTRP6 rapidly responds to acute nutritional changes, regulating adipose tissue expansion and inflammation in mice. Am J Physiol Endocrinol Metab. 2021;321(5):E702–E713. doi:10.1152/ajpendo.00299.2021
  • Lei X, Seldin MM, Little HC, et al. C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance. J Biol Chem. 2017;292(36):14836–14850. doi:10.1074/jbc.M116.766808